X4 Pharmaceuticals (XFOR) Competitors $1.82 -0.01 (-0.55%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$1.80 -0.02 (-1.04%) As of 07/25/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XFOR vs. JATT, CLSD, KZR, CLNN, OKUR, RNTX, FGEN, BDRX, ESLA, and MIRAShould you be buying X4 Pharmaceuticals stock or one of its competitors? The main competitors of X4 Pharmaceuticals include JATT Acquisition (JATT), Clearside Biomedical (CLSD), Kezar Life Sciences (KZR), Clene (CLNN), OnKure Therapeutics (OKUR), Rein Therapeutics (RNTX), FibroGen (FGEN), Biodexa Pharmaceuticals (BDRX), Estrella Immunopharma (ESLA), and MIRA Pharmaceuticals (MIRA). These companies are all part of the "pharmaceutical products" industry. X4 Pharmaceuticals vs. Its Competitors JATT Acquisition Clearside Biomedical Kezar Life Sciences Clene OnKure Therapeutics Rein Therapeutics FibroGen Biodexa Pharmaceuticals Estrella Immunopharma MIRA Pharmaceuticals JATT Acquisition (NYSE:JATT) and X4 Pharmaceuticals (NASDAQ:XFOR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Do analysts recommend JATT or XFOR? X4 Pharmaceuticals has a consensus target price of $72.33, suggesting a potential upside of 3,874.36%. Given X4 Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe X4 Pharmaceuticals is more favorable than JATT Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JATT Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00X4 Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals believe in JATT or XFOR? 48.0% of JATT Acquisition shares are held by institutional investors. Comparatively, 72.0% of X4 Pharmaceuticals shares are held by institutional investors. 20.0% of JATT Acquisition shares are held by insiders. Comparatively, 2.4% of X4 Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is JATT or XFOR more profitable? X4 Pharmaceuticals has a net margin of 46.54% compared to JATT Acquisition's net margin of 0.00%. JATT Acquisition's return on equity of -49.58% beat X4 Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% X4 Pharmaceuticals 46.54%-181.56%-54.36% Does the media refer more to JATT or XFOR? In the previous week, X4 Pharmaceuticals had 1 more articles in the media than JATT Acquisition. MarketBeat recorded 1 mentions for X4 Pharmaceuticals and 0 mentions for JATT Acquisition. X4 Pharmaceuticals' average media sentiment score of 1.89 beat JATT Acquisition's score of 0.00 indicating that X4 Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment JATT Acquisition Neutral X4 Pharmaceuticals Very Positive Which has preferable earnings & valuation, JATT or XFOR? JATT Acquisition has higher earnings, but lower revenue than X4 Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AX4 Pharmaceuticals$2.56M4.12-$37.45M$2.140.85 SummaryX4 Pharmaceuticals beats JATT Acquisition on 8 of the 12 factors compared between the two stocks. Get X4 Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for XFOR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XFOR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XFOR vs. The Competition Export to ExcelMetricX4 PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$10.59M$3.05B$5.70B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio0.8521.1828.3320.08Price / Sales4.12282.17430.8989.29Price / CashN/A42.7636.2258.56Price / Book0.478.378.675.88Net Income-$37.45M-$55.19M$3.25B$258.89M7 Day Performance27.27%5.86%4.23%3.71%1 Month Performance-9.00%17.29%10.50%11.72%1 Year Performance-92.96%4.39%34.42%18.00% X4 Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XFORX4 Pharmaceuticals4.9382 of 5 stars$1.82-0.5%$72.33+3,874.4%-93.0%$10.59M$2.56M0.8580Positive NewsJATTJATT AcquisitionN/A$1.91-2.6%N/A-54.6%$32.95MN/A0.003High Trading VolumeCLSDClearside Biomedical2.2924 of 5 stars$0.34-17.1%$4.20+1,138.9%-56.0%$31.78M$1.66M-0.8330High Trading VolumeKZRKezar Life Sciences4.1212 of 5 stars$4.30-1.1%$39.50+818.6%-34.5%$31.78M$7M0.0060CLNNClene3.4621 of 5 stars$3.87+1.3%$40.00+933.6%-18.2%$31.58M$340K0.00100OKUROnKure Therapeutics3.3887 of 5 stars$2.32-0.4%$32.33+1,293.7%N/A$31.48MN/A0.00N/APositive NewsRNTXRein TherapeuticsN/A$1.44+1.4%N/AN/A$31.46MN/A0.009Positive NewsGap DownFGENFibroGen4.5953 of 5 stars$7.56-1.2%$250.00+3,206.9%-75.8%$30.92M$29.62M-3.02570Positive NewsBDRXBiodexa Pharmaceuticals0.2928 of 5 stars$0.85+0.7%N/AN/A$30.86M$470K0.0020Positive NewsESLAEstrella Immunopharma3.2141 of 5 stars$0.84-1.5%$16.00+1,804.8%-47.9%$30.86MN/A0.00N/ANews CoverageGap DownMIRAMIRA Pharmaceuticals2.5957 of 5 stars$1.68-6.7%$14.00+733.3%-43.1%$30.45MN/A0.002 Related Companies and Tools Related Companies JATT Competitors CLSD Competitors KZR Competitors CLNN Competitors OKUR Competitors RNTX Competitors FGEN Competitors BDRX Competitors ESLA Competitors MIRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XFOR) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s Endgame? (R.I.P. China)Tucked inside a Silicon Valley factory, a bold new tech is quietly emerging—one that could ignite a $12 trilli...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredIt’s my duty to share the “truth” I see behind this bible verseFormer CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Goldco Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding X4 Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share X4 Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.